Levomepromazine for nausea and vomiting in advanced cancer

Levomepromazine for nausea and vomiting in advanced cancer

Skinner J; Skinner A

Hospital Medicine

1999

Humans; Palliative Care; Non-U.S. Gov't; Research Support; Neoplasms/complications; Dopamine Antagonists/adverse effects/therapeutic use; Methotrimeprazine/adverse effects/therapeutic use; Nausea/drug therapy/etiology; Vomiting/drug therapy/etiology

Levomepromazine (previously known as methotrimeprazine), despite virtually no high quality scientific data to support its use, has become a very popular antiemetic for use in patients with advanced cancer. This article considers the reasons for this.

1999

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Journal Article

Backlog